Appendix B. Sources of evidence considered by the Committee
A. The evidence review group (ERG) report for this appraisal was prepared by the School of Health and Related Research (ScHARR):
D Hind, P Tappenden, J Peters, K Kenjegalieva. Varenicline for smoking cessation: a single technology appraisal(March 2007).
B. The following organisations accepted the invitation to participate in this appraisal. They were invited to comment on the draft scope. Organisations listed in I were also invited to make written submissions. Organisations listed in II gave their expert views on varenicline by providing a written statement to the Committee. Organisations listed in I and II have the opportunity to appeal against the final appraisal determination.
I) Manufacturer/sponsor:
-
Pfizer Ltd
II) Professional/specialist and patient/carer groups:
-
Action Heart
-
British Heart Foundation
-
Burnley, Pendle and Rossendale PCT
-
Cancer Research UK
-
General Practice Airways Group
-
Macmillan Cancer Relief
-
National Lung Cancer Forum for Nurses
-
Primary Care Cardiovascular Society
-
Roy Castle Lung Cancer Foundation
-
Royal College of Nursing
-
Royal College of Physicians
-
Welsh Assembly Government
III) Commentator organisations (did not provide written evidence and without the right of appeal):
-
British National Formulary
-
British Society for Cardiovascular Research
-
Department of Health, Social Services and Public Safety for Northern Ireland
-
GlaxoSmithKline (Bupropion)
-
GlaxoSmithKline Consumer Healthcare (Nicotine)
-
Medicines and Healthcare Products Regulatory Agency (MHRA)
-
National Coordinating Centre for Health Technology Assessment
-
NHS Quality Improvement Scotland
-
School of Health and Related Research (ScHARR), University of Sheffield
C. The following individuals were selected from clinical specialist and patient advocate nominations from the professional/specialist and patient/carer groups. They gave their expert personal view on varenicline by providing written evidence to the Committee.
-
Dr Katherine Willmer, Consultant Cardiologist, nominated by the British Cardiovascular Society – clinical specialist
-
Mrs Christine Owens, Head of Tobacco Control of and nominated by the Roy Castle Lung Cancer Foundation – patient expert
-
Mr David Geldard, President, Heart Care Partnership (UK), nominated by the British Cardiovascular Society – patient expert